First Affiliated Hospital of Guangxi Medical University
185
48
59
38
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
2.2%
4 terminated/withdrawn out of 185 trials
90.5%
+3.9% vs industry average
16%
29 trials in Phase 3/4
5%
2 of 38 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (185)
Treatment of Clonorchiasis in Guangxi With Albendazole, Tribendimidine, and Praziquantel
Role: lead
Unknown Time of Onset Stroke RePerfusIon Without Advanced Imaging
Role: lead
CascadeDiagnose Prostate MRI
Role: lead
CD30 CAR-T in the Treatment of CD30 Positive Lymphoma
Role: collaborator
Federated Learning in Renal Tumor Model
Role: lead
Prospective Evaluation of the 2022 Optic Neuritis Criteria When Optic Neuritis Is Suspected
Role: lead
Chidamide in HR-AML
Role: collaborator
Intraoperative Midazolam on Delirium Outcome of Elderly Patients
Role: collaborator
Intravenous Tenecteplase in Very Old Patients With Acute Ischemic Stroke
Role: lead
FFR Versus IVUS With Angiography-Derived FFR for Clinical Outcomes in Patients With Coronary Artery Disease
Role: collaborator
Clinical Study of CLL-1 CAR-T in the Treatment of Children With R/R AML
Role: lead
Postoperative Anxiety and Depression Among Older Chinese Patients
Role: collaborator
Impacted Tooth Management and Osteoradionecrosis Risk in NPC
Role: lead
Toripalimab vs. Placebo Wtih GP Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
Role: collaborator
Phase III Trial of Concurrent Chemotherapy Alone in Patients With Low-risk Nasopharyngeal Carcinoma
Role: collaborator
China Children Eye Study
Role: collaborator
Preoperative Anxiety and Depression Among Older Chinese Patients
Role: collaborator
The Impact of Preoperative Depression on Postoperative Delirium in Elderly Chinese Patients: A Retrospective Multicenter Observational Study
Role: collaborator
Long-term Follow-up Study of BRL-101 for TDT
Role: collaborator
Safety and Efficacy Evaluation of BRL-101 in Subjects With Transfusion-Dependent β-Thalassemia
Role: collaborator